First results of a quantitative study of DNA adducts of melphalan in the rat by isotope dilution mass spectrometry using capillary liquid chromatography coupled to electrospray tandem mass spectrometry
- 14 June 2005
- journal article
- Published by Wiley in Rapid Communications in Mass Spectrometry
- Vol. 19 (14) , 1999-2004
- https://doi.org/10.1002/rcm.2018
Abstract
Rats were intravenously injected with a single high dose (10 mg/kg) of the alkylating agent melphalan in order to study DNA‐adduct formation. Quantitation of a dGuo‐melphalan adduct was done by isotope dilution mass spectrometry using capillary liquid chromatography/mass spectrometry (LC/MS) and [15N5]‐labeled dGuo‐melphalan as internal standard. DNA‐adduct levels were studied in bone marrow, liver and kidney. The instrumental detection limit of the method was determined to be 900 fg (S/N 3, pure standard). These first results clearly show a 10 times higher adduct level in bone marrow compared to kidney and a 6 times higher level compared to liver. More experiments will be necessary to gather more information on the pharmacokinetics of melphalan‐DNA adducts under in vivo conditions. Copyright © 2005 John Wiley & Sons, Ltd.Keywords
This publication has 23 references indexed in Scilit:
- Qualitative study ofin vivo melphalan adduct formation in the rat by miniaturized column-switching liquid chromatography coupled with electrospray mass spectrometryJournal of Mass Spectrometry, 2003
- Chemotherapy of multiple myeloma: Melphalan—40 years old and still going strongTransplantation and Cellular Therapy, 2003
- DNA Adducts, Mutations, and Cancer 2000Regulatory Toxicology and Pharmacology, 2000
- Liquid chromatography–mass spectrometry in nucleoside, nucleotide and modified nucleotide characterizationJournal of Chromatography A, 1998
- Products from alkylation of DNA in cells by melphalan: human soft tissue sarcoma cell line RD and Escherichia coli WP2Chemico-Biological Interactions, 1995
- 32P-Postlabeung Methods for DNA Adduct Detection: Overview and Critical EvaluationDrug Metabolism Reviews, 1994
- DNA adducts, mutations and cancerCarcinogenesis: Integrative Cancer Research, 1993
- Mass spectrometry for the analysis of carcinogen‐DNA adductsMass Spectrometry Reviews, 1992
- Comparison of 32P-postlabelling and cytogenetic analysis of human blood treated in vitro with melphalanMutagenesis, 1992
- Occurrence of second primary malignancies in man—a second lookCancer Treatment Reviews, 1985